Table 2.
Associations between NLR and clinicopathologic characteristics
| Variables | NLR < 2.39 (n = 78) | NLR ≥ 2.39 (n = 44) | P value |
|---|---|---|---|
| Age/years | 0.451 | ||
| < 60 | 37 (47.4%) | 24 (54.5%) | |
| ≥ 60 | 41 (52.6%) | 20 (45.5%) | |
| Gender | 0.596 | ||
| Male | 55 (70.5%) | 33 (75%) | |
| Female | 23 (29.5%) | 11 (25%) | |
| BMI | 0.187 | ||
| ≥ 25 | 38 (48.7%) | 16 (36.4%) | |
| < 25 | 40 (51.3%) | 28 (63.6%) | |
| Diabetes/hyperglycemia, n (%) | 0.363 | ||
| No | 67 (85.9%) | 35 (79.5%) | |
| Yes | 11 (14.1%) | 9 (250.5%) | |
| TNM stage (AJCC 8th) | 0.001a | ||
| I | 71 (91%) | 30 (68.2%) | |
| II | 4 (5.1%) | 6 (13.5%) | |
| III | 3 (3.9%) | 5 (11.5%) | |
| IV | 0 | 3 (6.8%) | |
| Surgical type | 0.063 | ||
| RN | 36 (46.2%) | 28 (63.6%) | |
| PN | 42 (53.8%) | 16 (36.4%) | |
| Tumor size (cm) | 0.011 | ||
| < 7 | 68 (87.2%) | 30 (68.2%) | |
| ≥ 7 | 10 (12.8%) | 14 (31.8%) | |
| Subtype, n (%) | 0.022 | ||
| I | 47 (60.3%) | 17 (38.6%) | |
| II | 31 (39.7%) | 27 (61.4%) | |
| Serum album (g/l) | 0.925 | ||
| ≥ 40 | 45 (57.7%) | 25 (56.8%) | |
| < 40 | 33 (42.3%) | 19 (43.2%) | |
| CHOL | 0.085 | ||
| < 4.90 | 37 (47.4%) | 28 (63.6%) | |
| ≥ 4.90 | 41 (52.6%) | 16 (36.4%) | |
| BUN/Cr | 0.274 | ||
| < 20 | 53 (67.9%) | 34 (77.3%) | |
| ≥ 20 | 25 (32.1%) | 10 (22.7%) |
TNM tumor-node-metastasis, CHOL cholesterol, NLR neutrophil-to-lymphocyte ratio, PN partial nephrectomy, RN radical nephrectomy
aMann–Whitney U